SCHEMBL27250071

SCHEMBL27250071

Cn1cnc2c(N3CCN(C(=O)OC(C)(C)C)CC3)cccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 2/20 0.47
SKP1 P63208 2/20 0.47
SKP2 Q13309 2/20 0.47
GPR119 Q8TDV5 5/20 0.45
MAP4K4 O95819 1/20 0.45
POLB P06746 1/20 0.45
SMARCA2 P51531 1/20 0.44
SMARCA4 P51532 1/20 0.44
PBRM1 Q86U86 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
PARP1 P09874 1/20 0.43
ACHE P22303 1/20 0.43
PIK3CD O00329 1/20 0.43
KIT P10721 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27249593 0.84 ALDH1A1 (0.52) CKS1BSKP1SKP2ALDH1A1LMNA
SCHEMBL25103465 0.81 SMARCA2 (0.47) CKS1BSKP1SKP2GPR119MAP4K4
SCHEMBL27250066 0.81 TSHR (0.45) MAP4K4ALDH1A1LMNA
SCHEMBL25104327 0.80 MAP4K4 (0.46) CKS1BSKP1SKP2GPR119MAP4K4
SCHEMBL4863963 0.78 CHRM2 (0.48) CKS1BSKP1SKP2GPR119SMARCA2
SCHEMBL1048457 0.78 POLB (0.55) CKS1BSKP1SKP2GPR119MAP4K4
SCHEMBL5363583 0.78 MAP4K4 (0.52) CKS1BSKP1SKP2GPR119MAP4K4
SCHEMBL23131531 0.78 DRD2 (0.46) ALDH1A1LMNAMAPT
SCHEMBL29337387 0.76 DRD2 (0.51) CKS1BSKP1SKP2GPR119MAP4K4
SCHEMBL20135184 0.76 SCN9A (0.47) CKS1BSKP1SKP2SMARCA2SMARCA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
WO-2024077391-A1 THIAZOLO[5,4-D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF UNIVERSITE DE MONTREAL (CA) 2024-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS CKS1B 205/4885SKP1 399/4885SKP2 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.